Atrial septal defect

Q17_ASD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q21.1 Hospital discharge: ICD-9 — 7455A\|7456A Hospital discharge: excluded ICD-10 — Q20\|Q2111\|Q2[2-5]\|Q26[0-1]\|Q26[5-9] Cause of death: ICD-10 — Q21.1 Cause of death: ICD-9 — 7455A\|7456A Cause of death: excluded ICD-10 — Q20\|Q2111\|Q2[2-5]\|Q26[0-1]\|Q26[5-9] Operations: NOMESCO codes — ^FFC00\|^FFC02\|^FFC22\|^FFC50\|^FFC96 3 out of 7 registries used, show all original rules.	1466
4. Check minimum number of events None	1466
5. Include endpoints None	1466
6. Filter based on genotype QC (FinnGen only)	1466

Control definitions (FinnGen only)

Control exclude: Q17_CONGEN_MALFO_CIRCULATO_SYSTEM

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF6v3

NAME	Q17_ASD
CONTROL_EXCLUDE	Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q211
HD_ICD_9	7455A\|7456A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	Q20\|Q2111\|Q2[2-5]\|Q26[0-1]\|Q26[5-9]
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q211
COD_ICD_9	7455A\|7456A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	Q20\|Q2111\|Q2[2-5]\|Q26[0-1]\|Q26[5-9]
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^FFC00\|^FFC02\|^FFC22\|^FFC50\|^FFC96
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Atrial septal defect based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13463	7684	5736
Only index persons	10427	6013	4414
Unadjusted period prevalence (%)
Whole population	0.19	0.22	0.16
Only index persons	0.20	0.22	0.17
Median age at first event (years)
Whole population	10.26	11.40	8.49
Only index persons	19.79	22.50	16.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1466	900	566
Unadjusted period prevalence (%)	0.28	0.31	0.25
Median age at first event (years)	41.27	39.57	43.98

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1344: Matched controls
13352

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q21.10

ICD-10 Finland

Persistent ostium secundum

+∞

323.0

746

FFC22

NOMESCO Finland

Percutaneous transluminal closure of ostium secundum type ASD

+∞

323.0

354

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

47.6

323.0

624

238

Q21.19

ICD-10 Finland

Atrial septal defect NOS

+∞

323.0

387

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

+∞

322.5

297

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

10.0

242.5

566

907

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.1

227.7

632

1318

XF620

NOMESCO Finland

Examination of circulation with color method

458.9

203.5

199

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

26.8

200.6

284

132

FFC00

NOMESCO Finland

Suture of ostium secundum type ASD

+∞

191.9

180

B01AA03

ATC

warfarin; systemic

7.5

165.3

450

838

XF400

NOMESCO Finland

ECG with 12 standard connections

5.4

126.7

456

1158

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.0

124.9

772

3335

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

+∞

122.5

116

7455A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect

+∞

121.4

115

Congenital heart failure surgery

+∞

112.8

107

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

+∞

102.1

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

1047.0

101.2

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

37.2

95.6

123

201

Kela drug reimbursment

Chronic cardiac insufficiency

12.3

92.9

175

160

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

7.2

92.7

243

395

XF404

NOMESCO Finland

Ambulatory ECG

6.1

90.5

271

527

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

9.3

87.7

193

237

I48

ICD-10 Finland

Atrial fibrillation and flutter

4.6

85.4

346

941

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

6.2

85.2

253

484

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

17.8

84.9

136

Q21.18

ICD-10 Finland

Other spedified atrial septal defect

+∞

84.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

4.4

83.4

355

1011

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.3

78.6

339

971

C03CA01

ATC

furosemide; systemic

3.8

77.2

398

1335

5205

FHL

ASD blockage, secondary defect

+∞

71.3

FM2CE

NOMESCO Finland

10.4

68.6

140

148

Q21.9

ICD-10 Finland

Congenital malformation of cardiac septum, unspecified

+∞

64.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.6

63.9

203

413

C01AA05

ATC

digoxin; systemic

7.2

63.3

163

252

PA2AE

NOMESCO Finland

Ultrasound examination of brain artery

621.0

61.1

WX872

NOMESCO Finland

Intensive care

8.1

60.5

143

194

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

20.2

58.0

WX408

NOMESCO Finland

General anesthesy, balanced

2.8

57.8

510

2415

Q25.0

ICD-10 Finland

Patent ductus arteriosus

+∞

55.4

C03DA01

ATC

spironolactone; oral

4.8

55.0

198

460

74642

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium secundum

193.2

54.2

Q25.1

ICD-10 Finland

Coarctation of aorta

545.2

53.8

C07AB07

ATC

bisoprolol; oral

2.6

52.9

566

2955

TPH07

NOMESCO Finland

Cathetrisation of artery

4.2

52.8

225

616

ZXD10

NOMESCO Finland

Scheduled procedure

2.4

50.6

630

3543

207

Kela drug reimbursment

Chronic arrhythmias

4.1

50.3

216

594

Q21.1

ICD-10 Finland

Atrial septal defect

+∞

49.1

FFC50

NOMESCO Finland

Closure of ostium secundum type ASD using patch

+∞

49.1

TFP20

NOMESCO Finland

Cardiodefibrillation

5.6

48.4

150

293

XF622

NOMESCO Finland

Measurement of minute volume of heart

107.3

48.0

Catheterization and pressure measurement of the right side of the heart

49.1

47.2

Q23.11

ICD-10 Finland

Bicuspid aortic valve

+∞

47.0

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

8.8

46.2

102

123

XF402

NOMESCO Finland

ECG with work load test

4.0

45.9

199

550

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

7.4

45.7

113

163

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

45.4

414

1942

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

47.3

45.3

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

448.8

44.4

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

7.1

43.6

111

167

XA800

NOMESCO Finland

Neuropsychological investigation

4.5

43.1

165

404

WX892

NOMESCO Finland

Monitored bed care

4.1

42.9

181

486

APK

ASD closure

+∞

42.8

Catheterization and pressure measurement of the left side of the heart

17.9

42.6

AF1

Surgery of congenital heart defect

+∞

41.8

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

41.7

551

3103

ZXE20

NOMESCO Finland

More than three and less than five hours

3.1

40.8

258

954

Q21.20

ICD-10 Finland

Atrial septal defect of primum type

+∞

39.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.8

39.3

139

313

APJ

PFO closure

+∞

37.6

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.8

37.3

173

503

7456A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[DEFECTUS SEPTI ATRIORUM NUD]

+∞

35.5

Q21.21

ICD-10 Finland

Atrioventricular duct

+∞

35.5

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.2

35.4

116

240

I50.9

ICD-10 Finland

Heart failure, unspecified

3.7

35.0

165

485

B01AC04

ATC

clopidogrel; oral

3.3

34.5

194

655

5253

FHL

Cardiac lung machine

33.0

34.5

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

6.1

34.3

168

Q21.12

ICD-10 Finland

Defective sinus venosus

+∞

33.4

I34.1

ICD-10 Finland

Mitral (valve) prolapse

8.3

33.2

K78

ICPC

Atrial fibrillation/flutter

4.6

32.9

121

283

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

15.0

32.3

R4110

NOMESCO Finland

Physiotherapy

2.2

32.3

427

2336

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

12.8

32.3

Z2221

NOMESCO Finland

Medical doctor

2.2

32.0

450

2529

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

115.3

31.7

XF600

NOMESCO Finland

Bloodpressure measurement

3.3

29.3

157

509

R4150

NOMESCO Finland

Neuropsychological rehabilitation

18.4

29.2

Q20.3

ICD-10 Finland

Discordant ventriculoarterial connection

+∞

29.2

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

28.9

306

1496

FFC42

NOMESCO Finland

Percutaneous closure of patent foramen ovale

+∞

28.1

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.1

28.0

167

583

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

10.0

27.7

AA1AD

NOMESCO Finland

CT of head and brain

2.4

27.2

278

1332

Q20.1

ICD-10 Finland

Double outlet right ventricle

+∞

27.1

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

274.3

26.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

25.5

263

1260

I50.0

ICD-10 Finland

Congestive heart failure

4.7

25.5

202

R4120

NOMESCO Finland

Occupational therapy

3.3

25.2

136

442

Q21.0

ICD-10 Finland

Ventricular septal defect

+∞

25.0

Q26.3

ICD-10 Finland

Partial anomalous pulmonary venous connection

+∞

25.0

Q20.48

ICD-10 Finland

Single ventricle

+∞

25.0

B01AB05

ATC

enoxaparin; parenteral

2.1

24.5

342

1878

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.8

24.3

106

291

XFE00

NOMESCO Finland

Epicardial ultrasonography

7.4

24.1

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.5

24.0

135

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

4.2

23.8

231

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.0

23.2

141

497

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

20.3

23.0

AP2

Catheterization of the right side of the heart

36.7

23.0

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

8.3

22.9

74639

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

84.3

22.7

WX882

NOMESCO Finland

High dependency care

3.3

22.6

121

391

AN1

Coronary angiography

3.1

22.3

132

458

ZXD05

NOMESCO Finland

Urgent procedure

1.9

21.9

416

2553

Q23.10

ICD-10 Finland

Congenital insufficiency of aortic valve

+∞

21.9

C07AA07

ATC

sotalol; systemic

5.5

21.8

125

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

21.8

305

1667

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

14.0

21.8

I49.5

ICD-10 Finland

Sick sinus syndrome

5.3

21.4

128

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.2

21.4

205

AP3

Catheterization of the right and left side of the heart

50.5

21.1

Q21.30

ICD-10 Finland

Tetralogy of Fallot

+∞

20.8

FFC96

NOMESCO Finland

Other closure of isolated atrial septal defect

+∞

20.8

Q26.1

ICD-10 Finland

Persistent left superior vena cava

+∞

20.8

7454B

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]

+∞

20.8

C01BD01

ATC

amiodarone; systemic

6.5

20.2

XX3BT

NOMESCO Finland

Other labeling with X-ray guidance

7.4

20.2

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

58.0

19.9

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

16.6

19.6

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

12.3

19.5

R06.0

ICD-10 Finland

Dyspnoea

2.0

19.2

286

1593

FDF05

NOMESCO Finland

Percutaneous transluminal occlusion of aorto-pulmonary collaterals

+∞

18.7

FHB50

NOMESCO Finland

Transatrial closure of VSD using patch

+∞

18.7

XF640

NOMESCO Finland

5.6

18.4

ZXE00

NOMESCO Finland

One hour or less

1.7

18.2

552

3878

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

18.0

147

618

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

+∞

17.7

Q23.4

ICD-10 Finland

Hypoplastic left heart syndrome

+∞

17.7

C09AA05

ATC

ramipril; oral

2.0

17.5

236

1257

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

95.6

17.5

K90

ICPC

Stroke/cerebrovascular accident

6.2

17.4

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.7

17.3

129

C07AB02

ATC

metoprolol; systemic

2.1

17.2

208

1059

C01BC04

ATC

flecainide; systemic

4.8

17.0

122

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

25.8

16.9

TFP34

NOMESCO Finland

Electrophysiological investigation

4.9

16.7

116

Q25.40

ICD-10 Finland

Aortic hypoplasia

+∞

16.7

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

+∞

16.7

FBE10

NOMESCO Finland

Expansion or reconstruction of pulmonary artery using patch

+∞

16.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

16.6

298

1764

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

12.8

16.6

Z3231

NOMESCO Finland

Registered nurse

1.7

16.5

421

2792

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

4.0

16.5

169

I49.3

ICD-10 Finland

Ventricular premature depolarization

3.1

16.4

313

G04BE03

ATC

sildenafil; oral

9.6

16.4

WX704

NOMESCO Finland

Intubation

2.8

16.1

110

418

Angiography of the heart and coronary arteries

3.8

15.9

185

WX402

NOMESCO Finland

General anaesthesia

1.9

15.8

267

1543

FAE00

NOMESCO Finland

Anastomosis to pulmonary artery from superior vena cava

+∞

15.6

FFC32

NOMESCO Finland

Percutaneous transluminal closure of sinus venosus type ASD

+∞

15.6

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

296

504

7.05

171.42

3.7

6.3

94.9

92.9

0.69

288

483

(3032080) INR in Blood by Coagulation assay

881

3702

4.42

171.38

14.9

7.2

inr

1.5

1.2

10.62

189

1105

(3018677) aPTT in Platelet poor plasma by Coagulation assay

554

1674

4.68

168.06

3.6

3.5

31.0

29.9

3.22

544

1630

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

656

2326

4.26

159.17

6.0

3.2

ng/l

1134.3

1069.9

0.18

596

1929

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

297

651

5.43

130.38

3.6

3.4

ng/l

221.0

175.0

0.74

260

582

(4306422)

152

167

9.97

126.49

1.1

1.2

—

(3036489) Thrombin time

258

547

5.47

116.96

3.2

5.0

21.6

22.1

0.71

217

508

(3033658) Prothrombin time (PT) actual/Normal

645

2877

3.19

100.18

6.0

5.4

80.5

91.8

21.33

638

2808

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

605

2636

3.18

97.27

2.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

136

182

8.08

96.32

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

136

195

7.53

90.63

1.3

u/ml

4.0

4.9

0.30

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

460

1789

3.26

88.41

4.1

3.5

ng/l

1355.9

469.2

2.12

368

1220

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

110

129

9.07

86.62

1.1

96.9

94.8

0.27

110

122

(3044640) Blood type and Crossmatch panel - Blood

674

3389

2.80

79.83

2.7

2.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

125

194

6.90

77.29

1.4

1.3

u/ml

3.9

2.9

0.24

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

855

5058

2.63

70.18

4.0

4.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

298

1019

3.39

69.07

44.2

18.6

inr

2.0

1.2

5.13

150

(3034426) Prothrombin time (PT)

15.06

63.67

1.2

1.4

—

(4268621)

133

7.09

58.03

2.6

2.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

219

715

3.40

53.87

2.2

2.3

ug/l

16.0

6.8

3.83

196

626

(3012095) Magnesium [Moles/volume] in Serum or Plasma

377

1707

2.61

51.05

6.9

6.3

mmol/l

0.8

0.70

361

1615

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

536

2931

2.29

47.09

2.7

2.3

u/l

247.5

252.4

0.04

511

2785

(3044889) 12 lead EKG panel

1006

7094

2.30

46.87

5.0

3.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

161

478

3.63

45.59

4.6

5.9

g/l

3.0

3.3

1.64

156

461

(3013826) Glucose [Moles/volume] in Serum or Plasma

947

6676

2.15

41.79

8.1

5.5

mmol/l

6.2

6.5

5.69

905

6219

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

109

261

4.40

41.51

11.1

7.2

u/ml

0.3

0.4

0.14

140

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

13.06

37.23

4.0

9.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

13.67

37.17

3.7

9.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

9.49

34.28

1.0

100.0

94.7

0.43

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

553

3441

1.96

31.67

4.7

3.3

ng/l

59.6

45.0

0.36

379

2123

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

228

1029

2.42

29.70

15.5

9.0

kpa

5.3

5.2

1.41

223

990

(3027801) Oxygen [Partial pressure] in Arterial blood

228

1029

2.42

29.70

15.5

9.0

kpa

13.2

12.7

0.47

223

994

(3003396) Base excess in Arterial blood by calculation

227

1031

2.40

29.13

15.6

9.0

mmol/l

1.2

1.0

0.27

198

823

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

6.85

28.71

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

138

494

2.96

28.47

21.6

12.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

6.40

26.38

1.0

1.1

ratio

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1352

11773

2.81

26.13

23.2

14.3

mmol/l

139.5

139.6

0.76

1344

11465

(3023103) Potassium [Moles/volume] in Serum or Plasma

1353

11794

2.81

25.94

23.2

14.4

mmol/l

4.0

1.62

1344

11456

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

728

5199

1.78

25.13

12.5

8.4

mmol/l

1.2

7.97

686

4793

(3000991) Gas panel - Venous blood

270

1410

2.11

24.41

15.3

10.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

407

2456

1.89

24.34

3.2

2.5

mg/l

1.2

1.3

0.08

295

1837

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

40.50

22.63

2.6

4.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

143

590

2.56

22.35

20.3

10.8

0.7

0.20

143

585

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

143

594

2.54

22.04

20.0

10.7

1.3

1.4

0.77

143

588

(42870588) Differential panel, method unspecified - Blood

635

4514

1.70

21.05

6.8

7.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

264

1448

1.99

20.59

16.1

12.8

mmol/l

25.4

24.6

5.64

264

1442

(3002173) Hemoglobin [Mass/volume] in Arterial blood

177

835

2.26

20.48

14.2

9.7

g/l

121.1

122.5

0.36

170

813

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

755

5646

1.68

20.46

10.8

8.6

mmol/l

1.2

5.67

673

4927

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

733

5452

1.67

20.18

8.7

6.8

umol/l

16.9

14.1

2.07

690

5140

(3024561) Albumin [Mass/volume] in Serum or Plasma

625

4466

1.68

20.02

5.8

5.7

g/l

36.3

0.08

585

4194

(3003458) Phosphate [Moles/volume] in Serum or Plasma

307

1796

1.88

19.69

8.4

8.2

mmol/l

1.2

1.06

298

1689

(3003694) ABO and Rh group [Type] in Blood

514

3503

1.70

19.57

1.4

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

266

1487

1.95

19.56

3.3

2.7

21.2

22.9

1.47

247

1329

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1347

11998

2.42

19.54

18.7

12.6

mg/l

23.8

22.2

1.11

1120

9074

(3023368) Bacteria identified in Blood by Culture

410

2625

1.76

19.52

4.6

4.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

299

1747

1.88

19.20

3.2

2.6

umol/l

12.8

13.6

1.30

282

1637

(3024928) Oxygen saturation in Venous blood

264

3.13

18.96

5.7

10.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

279

1600

1.90

18.96

3.2

2.6

g/l

2.4

0.16

263

1501

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

285

1671

1.86

18.00

1.9

2.0

—

(3022313) Gas panel - Capillary blood

215

1150

2.00

17.85

10.2

8.1

—

(3013512) EKG study

400

2603

1.72

17.71

5.8

3.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

198

1047

2.02

16.94

17.3

9.2

mmol/l

1.3

1.4

0.45

193

979

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

206

1109

1.98

16.74

4.5

5.0

u/l

267.5

270.6

0.06

198

1058

(3001604) Monocytes [#/volume] in Blood

816

6415

1.59

16.64

6.9

7.5

e9/l

0.6

0.98

707

5468

(3019198) Lymphocytes [#/volume] in Blood

835

6603

1.59

16.58

6.9

7.5

e9/l

1.9

2.1

5.10

738

5759

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

242

1384

1.88

16.41

9.9

7.8

mmol/l

1.8

1.0

5.96

199

989

(3006315) Basophils [#/volume] in Blood

815

6426

1.58

16.24

7.0

7.5

e9/l

0.0

0.69

708

5478

(3009343) pH of Capillary blood

244

1410

1.86

15.99

9.9

7.8

7.4

0.24

(3027456) Digoxin [Moles/volume] in Serum or Plasma

133

3.75

15.75

3.0

nmol/l

0.8

0.9

0.25

105

(3002032) Base excess in Venous blood by calculation

264

1578

1.81

15.47

6.5

7.8

mmol/l

1.5

1.4

0.03

222

1259

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

164

3.42

15.38

8.5

6.7

mg/l

11.8

11.2

0.28

152

(3013115) Eosinophils [#/volume] in Blood

830

6633

1.56

15.12

7.4

8.1

e9/l

0.2

1.99

733

5759

(40761511) CBC panel - Blood by Automated count

1364

12434

2.28

14.95

17.7

11.1

—

(3022096) Basophils/100 leukocytes in Blood

756

5940

1.54

14.69

7.3

7.8

0.7

0.22

721

5632

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

394

2.49

14.65

2.5

2.1

g/l

1.2

1.4

1.92

349

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

211

1197

1.88

14.58

7.0

8.7

mmol/l

24.2

23.7

1.40

205

1138

(3019069) Monocytes/100 leukocytes in Blood

775

6142

1.54

14.34

7.4

7.9

8.8

8.4

2.96

741

5834

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.89

14.15

2.1

1.3

e6/l

27184.8

32817.5

0.14

(3012441) Differential panel - Pleural fluid

4.76

14.13

2.0

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

794

6351

1.53

13.89

7.2

7.6

28.6

31.4

10.49

755

6017

(44806071)

8.98

13.67

1.1

—

(3006504) Eosinophils/100 leukocytes in Blood

767

6111

1.52

13.52

7.2

7.7

2.9

3.0

0.76

733

5776

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

414

2914

1.57

12.75

2.8

2.5

mg/l

3.2

2.9

1.55

370

2525

(3018010) Neutrophils/100 leukocytes in Blood

778

6264

1.50

12.72

6.9

7.4

56.3

53.6

7.72

744

5954

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

207

1218

1.80

12.63

1.8

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

4.41

12.52

2.1

1.3

e6/l

1520.3

1869.8

0.23

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

205

1216

1.78

12.16

1.8

1.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

511

3810

1.51

11.94

4.3

3.8

u/l

33.3

32.8

0.05

484

3635

(3013650) Neutrophils [#/volume] in Blood by Automated count

872

7253

1.48

11.67

9.2

10.1

e9/l

3.9

0.06

769

6232

(40758558) Short blood count panel - Blood

474

3498

1.51

11.55

6.7

8.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

224

1388

1.71

11.36

4.9

4.7

umol/l

8.6

7.5

0.43

204

1171

(3013707) Erythrocyte sedimentation rate by Westergren method

994

8512

1.50

11.30

4.7

4.1

mm/h

10.3

10.4

0.09

950

7939

(3011648) Oxygen content in Venous blood

126

3.30

11.00

5.5

17.1

11.5

11.3

0.21

126

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

975

8340

1.48

10.96

8.4

6.9

u/l

89.1

90.0

0.16

930

7831

(3019060) Gas panel - Arterial blood

110

553

2.05

10.74

6.3

5.7

—

(3018418) pH of Serum or Plasma

408

2964

1.51

10.55

4.3

3.9

7.4

0.02

536

(3021589) Normoblasts [#/volume] in Blood

720

5848

1.44

10.41

9.9

10.2

e9/l

0.0

0.11

576

4650

(3042936) Bacteria identified in Isolate by Culture

231

1477

1.66

10.36

2.6

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

133

726

1.90

10.26

2.1

3.1

g/l

65.0

66.4

0.97

120

671

(3027945) Reticulocytes/100 erythrocytes in Blood

214

1351

1.67

10.07

3.4

4.6

1.9

1.6

1.95

199

1244

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.83

9.98

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

4.26

9.75

2.1

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

353

2.23

9.53

1.7

2.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

348

2.23

9.43

1.7

2.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

268

2.39

9.27

1.9

2.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

288

2.34

9.17

1.7

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

677

5519

1.41

9.16

3.7

3.0

ug/l

108.2

96.5

0.74

637

5175

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

136

780

1.81

8.98

2.6

ml/min/173m2

70.0

70.9

0.08

300

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.33

8.61

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.78

8.26

1.5

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

916

7935

1.39

8.25

4.6

4.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

480

1.94

7.81

1.1

1.5

—

11.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.98

7.54

1.3

72.7

86.6

0.59

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.90

7.36

1.2

1.0

79.9

89.3

0.53

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.40

7.36

1.2

1.0

77.3

87.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

530

1.85

7.19

9.9

8.0

mmol/l

24.8

24.5

0.23

499

(3051593) INR in Capillary blood by Coagulation assay

5.01

7.12

1.1

12.1

—

(3023520) Reticulocytes [#/volume] in Blood

154

984

1.62

6.86

3.1

3.6

e9/l

78.1

68.7

1.74

109

694

(3019309) Folate [Moles/volume] in Red Blood Cells

224

1560

1.50

6.82

1.7

nmol/l

1146.7

1196.7

0.35

170

1183

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1087

9814

1.39

6.80

16.5

10.8

ml/min/173m2

87.4

87.5

0.05

944

7774

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

169

1115

1.57

6.58

8.2

6.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

3.05

6.55

41.8

41.0

ug/l

7.3

6.7

0.90

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.15

6.49

2.2

2.0

—

(3012501) Base excess in Blood by calculation

214

2.27

6.43

6.9

5.2

mmol/l

1.7

2.3

1.41

134

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

2.46

6.29

1.4

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

217

2.24

6.23

1.4

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

198

2.30

6.23

1.6

—

(3030467) Casts [#/volume] in Urine by Automated count

420

3326

1.36

6.18

3.9

3.5

e6/l

0.5

0.4

0.33

332

2472

(3002385) Erythrocyte distribution width [Ratio]

1165

10694

1.40

6.17

22.6

15.9

13.6

13.5

2.22

1153

10485

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.87

6.14

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.87

6.14

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.87

6.14

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

238

2.17

6.14

1.4

2.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

538

1.77

6.02

1.8

2.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

315

2.00

5.98

1.5

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.00

5.84

2.2

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.00

5.84

2.2

2.0

—

(40768806) Pleura Pathology biopsy report

3.12

5.83

2.3

1.6

—

(3018095) Leukocytes [#/volume] in Urine

518

4265

1.32

5.77

4.5

4.2

e6/l

40.8

85.7

1.89

376

2918

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

115

719

1.64

5.61

3.2

3.1

pmol/l

4.5

4.8

1.65

103

648

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.04

5.59

6.9

5.3

mg/l

115.0

71.5

0.62

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

303

1.97

5.54

2.5

2.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.81

5.48

1.4

1.0

52.8

70.0

—

(3037522) Nuclear Ab [Titer] in Serum

227

1654

1.43

5.44

1.4

titre

747.6

506.1

0.84

319

(3031040) Bacteria [#/volume] in Urine by Automated count

849

7514

1.29

5.32

4.8

4.2

e6/l

234.2

2668.5

1.64

(36304419) Bacteria [Presence] in Urine

408

3283

1.32

5.26

3.9

3.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

366

1.86

5.26

1.4

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

374

1.84

5.22

1.5

1.8

—

(3024731) MCV [Entitic volume]

1413

13586

1.91

5.19

27.6

18.4

89.7

89.3

2.18

1406

13415

(3035941) MCH [Entitic mass]

1413

13589

1.90

5.14

27.6

18.4

29.9

0.50

1406

13418

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.34

5.11

2.1

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.34

5.11

2.1

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.34

5.11

2.1

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.34

5.11

2.1

1.9

—

(3026361) Erythrocytes [#/volume] in Blood

1413

13591

1.90

5.10

27.7

18.5

e12/l

4.5

3.76

1387

13123

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

145

2.36

5.10

1.3

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

363

1.84

5.08

4.1

3.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

139

932

1.53

5.06

3.3

3.0

—

(3007461) Platelets [#/volume] in Blood

1412

13582

1.88

5.04

27.7

18.5

e9/l

246.2

259.8

12.35

1389

13154

(3010813) Leukocytes [#/volume] in Blood

1413

13596

1.89

5.02

27.7

18.5

e9/l

6.8

0.07

1390

13124

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

165

2.26

5.02

1.3

1.6

—

(44806118)

231

2.05

5.01

1.5

2.0

—

(44790048)

231

2.05

5.01

1.5

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

1413

13597

1.88

5.00

28.6

18.6

g/l

133.0

135.0

5.21

1407

13423

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

211

2.10

5.00

1.5

2.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

499

1.71

4.99

1.6

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

272

2074

1.37

4.98

2.7

3.0

e6/l

0.9

1.0

0.15

156

1159

(3002582) Erythrocytes [#/volume] in Urine

440

3601

1.30

4.97

4.0

3.6

e6/l

244.4

72.6

0.38

350

2730

(3000850) Epithelial cells [#/volume] in Urine

312

2435

1.35

4.92

3.5

2.8

e6/l

5.1

6.4

0.99

278

2123

(3009542) Hematocrit [Volume Fraction] of Blood

1246

11679

1.40

4.91

22.4

14.3

39.5

39.8

0.96

999

9386

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1163

10786

1.34

4.89

5.2

4.5

mu/l

2.0

2.1

0.40

1092

10031

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

3.48

4.84

1.6

1.1

u/l

10.3

12.0

0.24

(3023183) Ammonium ion [Moles/volume] in Plasma

347

1.84

4.84

2.5

3.7

umol/l

30.2

35.5

1.66

303

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

401

3252

1.31

4.83

2.9

2.6

u/l

62.5

56.2

1.25

372

3024

(44790047)

231

2.01

4.65

1.5

2.0

—

(44790049)

231

2.01

4.65

1.5

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

153

2.24

4.54

2.0

1.9

—

(40767503) Oxygen content in Capillary blood by calculation

214

2.03

4.46

3.0

2.7

17.3

16.7

0.41

125

(3000494) Fungus identified in Specimen by Culture

177

1282

1.42

4.38

1.8

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

426

3524

1.28

4.34

3.0

3.2

mmol/l

2.4

0.13

373

3137

(3021960) Folate [Moles/volume] in Serum or Plasma

279

2183

1.33

4.28

1.6

1.5

nmol/l

20.8

21.0

0.07

249

1881

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

248

1.91

4.16

1.5

2.1

g/l

37.5

38.2

0.23

221

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

844

7585

1.25

4.14

4.0

3.5

u/l

48.0

44.2

0.80

806

7186

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

263

1.88

4.12

1.9

2.2

g/l

0.5

1.0

0.79

241

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1039

9566

1.27

4.11

5.1

5.0

mmol/mol

37.9

39.0

3.93

977

8977

(3042733) HLA Ab [Presence] in Serum

2.86

4.01

5.1

3.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

324

1.78

4.00

1.5

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

377

1.72

3.98

2.2

2.0

—

(1616796) Gas panel - Central venous blood

231

1.92

3.96

5.7

4.3

—

(3051651) Icteric interference index of Serum or Plasma

111

2.35

3.94

5.3

4.6

—

(3020891) Body temperature

364

1.72

3.90

5.7

5.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

191

1430

1.38

3.90

2.1

1.7

—

(3021901) Oxygen saturation in Capillary blood

219

1.93

3.87

4.1

4.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

206

1.95

3.82

1.8

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

462

3916

1.25

3.75

2.1

1.8

pmol/l

99.3

96.3

0.68

260

2023

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

114

2.29

3.73

2.6

2.2

32.0

32.7

0.27

114

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

280

1.80

3.71

2.0

2.1

g/l

11.1

10.4

0.36

248

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

188

1.98

3.68

2.1

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

224

1.89

3.63

1.5

2.2

g/l

0.0

0.00

211

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

147

1066

1.41

3.63

2.4

u/l

38.4

82.6

0.47

129

888

(3005322) IgE [Units/volume] in Serum or Plasma

142

1025

1.42

3.60

1.2

1.4

u/ml

151.5

310.0

2.31

135

961

(3042631) Mycobacterium sp identified in Specimen

116

2.25

3.59

2.4

3.5

—

(3003338) MCHC [Mass/volume]

1171

11000

1.28

3.59

23.3

16.3

g/l

333.3

333.5

0.27

1166

10911

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

451

1.62

3.58

1.3

1.6

g/l

1.1

1.2

0.85

431

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

240

1.85

3.56

1.5

2.1

g/l

0.0

0.50

226

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

226

1.87

3.54

1.5

2.2

g/l

0.0

0.00

212

(3009871) Measles virus Ab [Titer] in Serum

2.94

3.53

1.5

1.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1.76

3.48

2.0

2.1

g/l

3.1

0.03

234

(3026493) Urate [Moles/volume] in Serum or Plasma

310

2529

1.28

3.45

3.7

3.0

umol/l

2712.1

5490.7

0.56

271

2234

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

107

739

1.47

3.44

1.9

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

126

2.15

3.37

1.2

1.1

—

(3026782) Osmolality of Urine

287

2327

1.28

3.35

3.7

2.9

mosm/kgh2o

558.7

559.7

0.02

258

1996

(3002331) Protein [Mass/volume] in Peritoneal fluid

4.99

3.35

1.7

g/l

38.6

21.4

—

(3021788) Differential panel - Synovial fluid

163

1.97

3.19

1.9

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

2.27

3.15

1.8

1.7

65.5

56.6

0.69

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

244

1.77

3.10

1.2

1.3

u/ml

36.8

6.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.54

3.08

1.8

1.5

25.2

33.1

—

(3026008) Bacteria identified in Urine by Culture

376

3178

1.24

3.05

3.0

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

619

1.47

2.99

1.8

1.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

249

2014

1.27

2.96

3.0

3.2

e6/l

3.2

2.5

0.46

135

1109

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.67

2.91

2.0

g/l

3.8

0.09

230

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.67

2.91

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1.67

2.91

2.0

g/l

7.0

7.4

0.88

240

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.14

2.90

1.5

4.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1292

12369

1.31

2.89

12.3

9.8

u/l

26.2

26.6

0.27

1263

11972

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

318

1.65

2.89

1.5

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

318

1.65

2.89

1.5

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

119

870

1.39

2.85

4.6

4.8

1.2

0.9

0.64

267

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

989

9205

1.21

2.84

4.5

3.9

pmol/l

14.8

14.6

2.78

918

8458

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.92

2.82

1.8

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

439

1.54

2.81

1.4

1.6

g/l

0.2

0.64

421

(3021440) Promyelocytes/100 leukocytes in Blood

114

830

1.39

2.80

4.7

4.9

0.3

0.1

0.83

249

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

124

916

1.38

2.79

5.5

5.4

ng/l

77.8

68.0

1.30

109

846

(3002179) Metamyelocytes/100 leukocytes in Blood

110

799

1.40

2.74

4.2

4.5

0.7

0.5

0.38

192

(3010726) Horse dander IgE Ab [Units/volume] in Serum

494

0.53

2.74

1.0

1.2

u/ml

1.0

4.5

—

165

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

233

1.72

2.68

1.7

1.4

—

(40761535) Cells panel - Urine sediment

107

779

1.39

2.64

3.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.39

2.59

1.1

iu/ml

226.9

222.4

0.02

(3025159) Blasts/100 leukocytes in Blood

108

791

1.38

2.58

4.7

5.0

0.1

0.5

0.52

209

(3011397) Hemoglobin [Presence] in Urine by Test strip

333

2825

1.22

2.57

3.3

3.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

313

1.61

2.57

1.2

1.3

u/ml

3.5

8.0

0.64

(3032057) Clostridioides difficile [Presence] in Stool

3.99

2.55

2.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.30

2.54

1.2

—

(40768797) Stomach Pathology biopsy report

183

1454

1.29

2.51

1.2

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

307

1.61

2.51

1.3

u/ml

2.1

5.0

—

(3044927) Protein electrophoresis panel - Urine

2.13

2.51

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

157

1.85

2.48

1.0

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

212

1719

1.26

2.47

2.4

2.7

mmol/l

2.4

1.57

179

1492

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

150

1.87

2.47

1.0

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

348

1.56

2.47

2.6

2.0

ug/l

0.8

2.2

0.95

312

(3051611) Lipemic interference index of Serum or Plasma

144

1.88

2.42

5.6

4.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

375

1.53

2.39

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

304

1.59

2.37

2.1

1.8

iu/l

5.2

5.3

0.01

105

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

344

1.55

2.36

1.9

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

508

0.58

2.36

1.0

1.2

u/ml

1.4

1.0

0.15

331

(3003888) Timothy IgE Ab [Units/volume] in Serum

520

0.58

2.35

1.0

1.2

u/ml

2.9

5.7

0.80

367

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

321

1.57

2.34

11.4

8.7

iu/ml

1013.0

322.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.21

2.34

1.3

1.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

168

1.79

2.32

3.5

3.9

1.1

1.4

0.19

135

(3004616) Nuclear Ab [Presence] in Serum

118

1.95

2.31

1.5

1.3

—

(40768804) Tissue Pathology biopsy report

462

4079

1.18

2.29

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

142

1106

1.30

2.28

3.4

g/l

10.1

9.7

0.43

134

1040

(42529406) Shigella sp [Presence] in Stool by Culture

388

1.50

2.27

1.2

—

(3035880) pH of Pleural fluid

2.68

2.25

1.2

—

(3002256) Pathology report gross observation

155

1225

1.29

2.24

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.02

2.22

1.4

1.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

382

1.50

2.21

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

279

1.58

2.18

2.7

2.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1084

10266

1.19

2.18

4.4

3.9

mmol/l

5.7

5.8

2.08

1008

9440

(3025941) Bacteria identified in Stool by Culture

668

1.38

2.18

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

557

0.61

2.17

1.1

1.2

u/ml

7.3

2.7

0.43

342

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.49

2.15

1.6

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.49

2.15

1.6

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.49

2.15

1.6

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.67

2.13

8.1

10.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

115

1.91

2.12

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

626

5692

1.16

2.11

3.6

3.4

estimate

0.0

0.00

1001

(3018405) Lactate [Moles/volume] in Arterial blood

314

1.54

2.10

5.9

4.0

mmol/l

1.2

1.4

1.50

306

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.98

2.06

2.4

1.8

—

(3014891) Appearance of Pleural fluid

4.98

2.06

1.8

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

146

1.78

2.03

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.98

2.02

2.2

2.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

261

1.58

2.02

3.1

2.5

g/l

137.6

131.3

0.93

202

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1108

10540

1.18

2.00

4.6

4.0

mmol/l

4.3

4.7

25.26

1050

9895

(3033799) Differential panel - Peritoneal fluid

3.07

2.00

2.4

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1240

0.75

1.97

1.7

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.96

1.97

1.9

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

294

0.50

1.96

1.0

1.1

u/ml

0.0

0.4

—

128

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

179

1.68

1.91

2.1

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

2.11

1.89

1.5

1.2

—

42.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

226

1903

1.21

1.88

1.3

iu/ml

17.5

28.2

3.00

548

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

548

0.64

1.88

1.5

1.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

314

0.53

1.86

1.1

u/ml

5.4

9.2

—

169

(3034274) Bile acid [Moles/volume] in Serum --fasting

291

1.52

1.86

4.4

4.1

umol/l

9.8

9.9

0.00

233

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.15

1.85

4.4

4.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

401

0.59

1.85

1.3

1.4

—

(3037121) Protein [Mass/volume] in Urine

516

1.39

1.85

4.1

5.8

g/l

0.2

0.3

0.94

313

(3029075) Extractable nuclear Ab panel - Serum

2.08

1.83

1.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

159

1.70

1.82

1.1

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

336

0.56

1.80

1.1

u/ml

1.9

8.1

—

178

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

624

1.34

1.76

1.5

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.32

1.73

1.0

1.1

—

(3019225) pH of Specimen

113

890

1.28

1.72

4.6

4.1

—

(3044007) Cell count panel - Peritoneal fluid

2.66

1.71

2.4

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.91

1.71

1.7

1.4

—

(21494755) Public health laboratory ask at order entry panel

1235

0.77

1.70

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

323

2834

1.17

1.69

1.6

1.7

mmol/l

1.3

1.4

0.66

278

2457

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

449

1.39

1.67

5.1

4.4

55.5

51.4

0.64

440

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1057

10069

1.15

1.66

4.2

3.6

mmol/l

1.2

1.3

4.99

991

9384

(3044290) Cell count panel - Cerebral spinal fluid

317

1.46

1.63

1.4

3.2

—

(4010399)

757

1.29

1.60

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

105

1.81

1.60

1.6

2.4

mg/l

41.2

25.3

—

(3003181) Sodium [Moles/volume] in Urine

206

1.55

1.56

1.3

2.3

mmol/l

77.1

72.7

0.16

180

(3011897) Casein IgE Ab [Units/volume] in Serum

125

0.40

1.50

1.4

1.7

—

9.6

—

(40757373) Influenza virus identified in Isolate

2.84

1.49

1.5

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.89

1.47

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.36

1.45

1.2

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

104

831

1.26

1.45

2.8

4.2

ug/l

3.7

17.1

1.50

670

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1111

10658

1.15

1.44

5.0

4.3

mmol/l

2.6

2.8

17.41

1041

9946

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

109

1.74

1.44

1.5

1.2

u/l

357.9

116.4

0.36

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.11

1.43

1.6

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

139

1152

1.22

1.40

4.3

4.0

34.0

31.7

1.54

109

797

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

345

1.39

1.4

2.8

mmol/l

3.6

0.12

329

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

237

1.48

1.38

4.9

4.3

56.0

55.9

0.02

237

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1092

10474

1.14

1.38

4.6

3.9

mmol/l

1.4

1.5

3.95

1030

9786

(4015189)

2.60

1.35

2.0

3.2

—

(3009261) Glucose [Presence] in Urine by Test strip

620

5759

1.12

1.35

3.7

3.5

estimate

0.0

0.80

100

997

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

105

848

1.25

1.35

2.1

2.3

au/ml

23.7

19.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

1.34

0.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

104

1.73

1.34

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

293

2603

1.15

1.30

5.0

4.9

—

(4027681)

105

1.71

1.30

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.77

1.30

2.6

3.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

614

5713

1.12

1.28

5.0

4.8

estimate

0.0

0.50

103

1034

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.73

1.28

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

177

1.52

1.26

1.9

3.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.21

1.23

1.1

1.6

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

0.3

1.3

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

1.6

6.3

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

1.4

1.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

1.8

2.0

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

1.5

1.6

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

0.3

0.8

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

1.9

1.5

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.21

1.23

2.3

1.9

mg/l

1.5

3.4

—

(3023419) Bacteria identified in Sputum by Culture

115

1.65

1.22

1.4

3.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

205

1.46

1.17

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

1.16

0.0

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.99

1.14

1.3

1.8

—

(3000012) Reticulocyte production index

1.99

1.14

1.1

1.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.49

1.14

1.4

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

362

3290

1.12

1.13

1.5

1.6

g/l

2.1

2.0

0.11

219

1846

(3020393) Adenovirus Ag [Presence] in Stool

110

1.63

1.13

1.3

2.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

118

1.61

1.12

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

118

1.61

1.12

1.2

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

224

1.43

1.11

1.9

1.8

e6/l

12377.1

14104.1

0.12

170

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

343

1.34

1.11

1.5

3.1

e6/l

2.1

7.5

1.68

260

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

343

1.34

1.11

1.5

3.1

e6/l

178.9

542.3

0.77

267

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.89

1.10

1.3

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

159

1.51

1.09

1.5

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1.59

1.09

1.2

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1.59

1.09

1.2

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1.59

1.09

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

151

1.52

1.09

1.4

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

151

1.52

1.09

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

234

1.41

1.08

2.0

3.6

mg/l

32.0

44.3

0.42

185

(3034860) Kappa light chains.free [Mass/volume] in Serum

234

1.41

1.08

2.0

3.6

mg/l

51.1

73.9

0.36

184

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

206

1813

1.15

1.06

1.3

1.2

u/ml

11.7

9.0

0.17

665

(3000570) Elastase.pancreatic [Mass/mass] in Stool

355

1.33

1.05

1.5

1.4

ug/g

266.2

318.9

0.87

204

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.92

1.04

1.3

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

497

1.27

1.03

2.3

2.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

786

1.21

1.02

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1016

0.82

1.00

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

142

1619

0.86

0.99

1.5

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

134

0.52

0.98

1.3

2.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.94

0.96

1.1

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

494

1.26

0.95

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

286

2592

1.12

0.95

3.4

3.3

mg/l

535.8

283.9

0.33

186

1699

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.84

0.95

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

326

0.70

0.94

4.7

2.2

nmol/l

0.8

0.7

0.33

279

(3017732) Neutrophils [#/volume] in Blood

803

1.20

0.94

2.3

2.7

e9/l

4.2

4.1

0.09

675

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

144

0.55

0.93

1.5

2.0

nmol/l

0.1

—

102

(3030905) Polymorphonuclear cells [#/volume] in Blood

233

1.37

0.92

4.3

3.9

e9/l

4.2

4.1

0.06

233

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

166

1.44

0.92

1.4

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.72

0.91

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.72

0.91

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

183

1.42

0.91

8.5

4.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

670

1.21

0.90

1.9

2.3

u/l

7442.8

4415.2

0.31

247

(3026389) Candida sp identified in Specimen by Organism specific culture

142

1.48

0.90

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.06

0.89

2.7

7.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

118

1.52

0.88

1.2

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.56

0.88

1.1

1.2

—

(3024263) Appearance of Synovial fluid

1.85

0.87

1.6

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.64

0.86

1.5

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

319

2925

1.11

0.86

4.1

3.7

estimate

0.0

1.28

1006

(40768441) Liver Pathology biopsy report

111

1.53

0.85

1.5

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.81

0.85

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

187

2066

0.88

0.85

2.1

2.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

389

3605

1.10

0.84

1.4

1.5

u/ml

0.9

2.7

5.31

820

(3014599) Egg white IgE Ab [Units/volume] in Serum

225

0.66

0.84

1.1

1.5

u/ml

10.3

15.5

—

145

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.93

0.84

2.3

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

178

1583

1.13

0.82

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.75

0.82

2.8

4.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.73

0.82

1.6

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

770

1.19

0.81

1.2

1.3

au/ml

15.9

42.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.87

0.81

1.8

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

527

0.79

0.80

1.6

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

188

1.38

0.80

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

400

1.25

0.78

1.5

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.16

0.76

1.6

1.8

—

(1002224) Polysomnography panel

465

1.23

0.75

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.69

0.75

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

278

1.29

0.74

1.7

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

502

1.22

0.74

1.5

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.07

0.74

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.66

0.74

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.66

0.74

1.9

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.66

0.74

1.9

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

287

0.72

0.74

1.4

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

1.44

0.74

1.4

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.83

0.73

2.7

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.99

0.72

1.2

1.8

—

(4198724)

100

1.49

0.71

1.3

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

171

1875

0.89

0.70

2.0

2.1

—

(3000492) Spirometry study

128

1128

1.14

0.70

1.7

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.91

0.70

3.0

2.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

185

1.35

0.69

1.5

1.4

u/l

17.2

19.9

0.20

157

(3014271) Vancomycin [Susceptibility]

1.70

0.69

2.3

2.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

449

4229

1.08

0.67

3.7

3.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.62

0.66

1.7

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

392

1.22

0.65

2.3

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

200

0.69

0.65

1.1

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

179

1.34

0.64

2.8

2.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.58

0.64

2.1

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.58

0.64

2.1

1.5

—

(4281824)

1.51

0.64

1.5

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

330

1.24

0.63

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

232

1.29

0.63

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

457

1.20

0.63

1.7

2.0

u/l

37.3

39.9

0.49

415

(3035933) Granulocytes/100 leukocytes in Blood

130

0.61

0.63

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

293

2722

1.09

0.61

4.1

4.0

mg/mmol

11.3

7.7

0.39

188

1768

(3010838) Calcium [Moles/time] in 24 hour Urine

1.62

0.61

1.3

1.4

—

10.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

143

1282

1.12

0.61

3.1

2.4

nmol/l

333.9

354.2

0.49

133

1206

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.54

0.60

1.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

190

1.31

0.60

3.0

4.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.58

0.60

1.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

230

0.73

0.59

1.0

1.5

u/ml

1.6

4.0

0.84

151

(3011288) Drugs identified in Urine by Screen method

536

0.83

0.58

2.5

2.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

165

1.33

0.58

1.0

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.52

0.57

1.2

1.8

—

(3020650) Glucose [Presence] in Urine

1.66

0.56

1.2

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.66

0.56

3.0

2.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.58

0.56

1.0

1.1

nmol/l

—

1.3

—

(3011412) CD3 cells [#/volume] in Blood

219

1.27

0.56

3.2

3.6

e9/l

1.2

1.5

1.16

143

(3019150) Specific gravity of Urine by Refractometry

273

2541

1.08

0.56

3.7

3.6

kg/l

1.0

0.11

381

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

490

0.83

0.56

1.6

1.7

mg/l

3.3

3.4

0.03

336

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.61

0.55

5.8

2.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.55

1.0

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

510

4857

1.07

0.55

3.0

2.6

nmol/l

76.0

74.4

0.62

461

4446

(3022621) pH of Urine by Test strip

681

0.85

0.55

2.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

328

1.22

0.54

1.3

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.52

0.54

4.3

3.5

ug/l

80.2

137.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.52

0.54

5.2

8.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.57

0.54

2.2

2.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.57

0.54

1.0

1.1

—

(40768443) Skin Pathology biopsy report

402

1.19

0.53

1.2

—

(3049233) Organic acids panel - Urine

1.53

0.52

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

766

1.14

0.52

1.3

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

125

1.35

0.52

1.3

1.5

—

29.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

187

1.28

0.50

2.5

3.8

—

(3009508) Creatinine [Moles/volume] in Urine

351

3312

1.07

0.50

3.5

3.6

mmol/l

7.5

7.8

0.54

303

2872

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

322

0.80

0.50

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.44

0.50

1.1

1.5

—

(3008898) HLA-B27 [Presence]

526

0.84

0.50

1.1

—

(1761868) Lipid panel - Serum or Plasma

382

3975

0.94

0.49

2.5

2.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

222

0.76

0.49

1.5

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

177

0.73

0.49

1.0

1.2

u/ml

0.2

0.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

142

0.70

0.47

2.6

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

189

1.27

0.47

1.2

—

(3027944) Amphetamines [Presence] in Urine

776

0.88

0.47

1.8

1.9

—

(3024932) HLA-DR beta [Type]

1.44

0.46

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

128

1.32

0.46

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.59

0.45

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

815

0.88

0.45

1.5

—

(3024471) HLA-A [Type]

1.42

0.44

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

247

2316

1.07

0.43

4.0

4.2

ug/l

1.6

2.1

1.70

215

2108

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.60

0.43

1.0

1.1

u/ml

41.1

33.8

—

(3002619) Bacteria identified in Specimen by Culture

1.60

0.43

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.55

0.42

2.8

2.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.55

0.42

1.0

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.37

0.41

1.3

1.1

miu/ml

1281.2

1556.7

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.41

0.0

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

536

1.14

0.40

2.6

2.8

e6/l

0.1

0.2

1.70

518

(3000285) Sodium [Moles/volume] in Blood

0.00

0.40

0.0

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

167

1548

1.08

0.40

1.6

1.7

1.4

0.03

151

1389

(46235355) HIV 1 and 2 tests - Meaningful Use set

294

2781

1.06

0.40

1.8

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

140

1.28

0.40

1.1

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.46

0.40

2.6

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

0.40

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

104

0.67

0.39

1.0

2.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.42

0.39

2.6

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

389

1.15

0.38

2.3

1.9

—

15.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.33

0.38

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.40

0.38

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.40

0.38

1.4

1.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.38

0.38

1.4

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.38

0.38

1.0

1.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

196

1.22

0.37

2.4

3.6

15.2

9.6

1.04

159

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

196

1.22

0.37

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

266

0.82

0.37

1.2

1.1

u/ml

1.8

4.5

—

104

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

190

0.78

0.37

1.1

—

(40768793) Breast Pathology biopsy report

233

0.81

0.36

1.6

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.26

0.36

3.1

3.4

u/ml

1256.4

969.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.38

0.35

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

373

1.15

0.35

2.3

1.9

u/ml

99.3

101.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.42

0.35

1.2

1.3

—

(3022670) pH of Venous cord blood

1.42

0.35

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

299

1.17

0.35

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1005

0.91

0.35

1.9

—

(3004451) EKG impression Narrative

1.39

0.35

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

231

0.81

0.34

1.0

mmol/l

19.4

0.03

223

(3017704) Immunofixation for Urine

1.36

0.34

1.5

1.6

—

(3016879) Cocaine [Presence] in Urine

725

0.90

0.34

1.8

2.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

401

0.86

0.34

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

263

1.17

0.34

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

878

1.09

0.33

2.3

2.2

nmol/l

11.1

11.9

0.39

747

(21494890) Protein electrophoresis panel - 24 hour Urine

1.36

0.33

1.2

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

452

0.88

0.32

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

108

996

1.08

0.32

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

265

1.17

0.31

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

605

1.10

0.31

1.8

1.9

u/l

9.0

7.4

0.41

410

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

115

1223

0.93

0.31

2.1

2.0

—

(21494434) Karyotype in Bone marrow

130

0.76

0.30

1.0

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.31

0.30

1.3

—

71.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

351

3367

1.05

0.30

1.9

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.29

0.30

2.3

3.4

mg/l

8.1

10.1

—

(3006598) pH of Arterial cord blood

227

0.83

0.30

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

227

0.83

0.30

1.0

mmol/l

-2.1

-2.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

102

942

1.08

0.30

1.2

iu/ml

139.2

148.0

0.07

353

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.27

0.29

4.4

7.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

417

1.12

0.29

1.4

1.3

—

(40761536) Microorganisms panel - Urine sediment

101

933

1.08

0.29

4.9

3.7

—

(4035726)

866

1.08

0.29

1.9

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

965

9453

1.04

0.29

3.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

236

2244

1.05

0.29

1.7

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.33

0.29

1.4

2.0

—

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

109

0.73

0.29

1.4

1.2

—

(4146454)

1.28

0.28

3.3

2.7

—

(3025130) Human papilloma virus identified in Specimen

150

0.79

0.28

1.5

1.7

—

(40768800) Prostate Pathology biopsy report

128

0.77

0.28

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

148

1.21

0.27

2.6

4.2

u/ml

11798.3

1961.7

0.38

141

(3000764) Benzodiazepines [Presence] in Urine

776

0.92

0.27

1.8

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.24

0.27

1.5

2.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.31

0.27

1.0

—

(4062490)

158

1.20

0.26

1.2

1.3

—

(3045424) Erythrocytes [Presence] in Urine

195

1.17

0.26

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

784

0.92

0.26

1.9

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

182

1892

0.95

0.26

2.0

2.8

ug/g

108.8

110.1

0.02

136

1530

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

196

1.17

0.25

3.3

3.6

e9/l

0.3

0.2

0.78

155

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.23

0.25

1.2

1.5

—

(3027008) Opiates [Presence] in Urine

782

0.92

0.25

1.8

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.18

0.24

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.74

0.24

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

378

0.89

0.24

1.3

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.34

0.23

1.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

367

0.89

0.23

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.24

0.23

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.31

0.23

1.2

1.4

ug/l

9.5

9.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

198

1.16

0.23

3.2

3.6

e6/l

364.7

539.9

1.58

155

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

245

1.14

0.23

1.5

1.3

pmol/l

86.9

126.9

0.40

239

(3022145) Colonoscopy Study observation

124

1168

1.06

0.23

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.27

0.22

3.2

6.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.27

0.22

3.6

6.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.24

0.22

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

407

0.90

0.22

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

551

1.08

0.22

1.6

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

341

1.11

0.21

1.6

1.5

titre

64.0

77.9

—

(3023410) Appearance of Cerebral spinal fluid

218

1.14

0.21

1.8

4.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

108

1132

0.94

0.21

1.7

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

406

0.90

0.21

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

406

0.90

0.21

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.24

0.21

1.3

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

8.9

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.21

0.0

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(40768446) Kidney Pathology biopsy report

1.26

0.21

2.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

100

0.79

0.21

1.0

1.1

mg/l

350.4

292.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

418

1.10

0.21

1.2

1.1

u/ml

3.2

6.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

125

1.19

0.21

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

228

1.13

0.21

4.1

4.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

405

0.90

0.21

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.20

0.0

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.20

0.0

6.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

784

0.93

0.20

1.4

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.27

0.20

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.20

0.0

1.7

—

(3016750) Collection duration of Urine

1.19

0.19

4.3

2.5

min

513.2

510.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

185

0.86

0.19

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

164

1.15

0.19

1.3

1.8

—

1474.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.15

0.19

1.2

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.23

0.17

1.1

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

266

0.89

0.17

2.2

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

232

1.11

0.17

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

185

1.13

0.16

1.8

3.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

521

1.07

0.16

1.2

—

(36660697) Celiac disease serology panel - Serum

139

1433

0.96

0.16

1.2

—

(3028433) Virus identified in Specimen by Culture

1.10

0.16

1.3

1.4

—

(44813793)

129

0.85

0.15

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

129

0.85

0.15

1.2

1.3

nmol/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

310

1.09

0.15

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.12

0.15

1.2

1.3

—

65.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

325

0.91

0.15

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

376

0.92

0.15

2.3

2.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

111

1.16

0.14

3.6

2.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

102

1.17

0.14

1.2

3.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

102

1.17

0.14

1.3

3.9

—

(3008037) Lactate [Moles/volume] in Venous blood

200

0.89

0.14

4.6

3.1

mmol/l

1.8

1.5

0.63

195

(3005033) Fetal Nuchal fold Thickness US

323

0.92

0.13

1.5

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

106

0.84

0.13

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

332

0.93

0.12

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

199

1.10

0.12

1.0

1.1

iu/ml

14.9

8.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.17

0.11

1.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.17

0.11

1.6

g/l

0.9

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

181

1.10

0.11

3.6

2.9

e6/l

531.5

719.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

201

1954

1.02

0.10

1.5

1.6

pmol/l

468.5

38253448.4

2.41

167

1660

(4034850)

327

1.06

0.10

14.3

8.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

134

1.11

0.09

6.7

4.2

umol/l

23.5

26.2

0.88

134

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

279

1.07

0.09

1.1

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.08

0.09

1.4

2.4

umol/l

14.8

18.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

231

1.08

0.09

1.2

1.7

g/l

0.6

0.8

0.41

192

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

106

1.13

0.09

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

319

1.06

0.09

5.3

4.0

nmol/l

24.9

21.8

0.48

311

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.08

0.08

1.3

1.4

—

86.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

153

0.91

0.08

1.0

1.3

u/ml

3.5

24.1

—

118

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

242

1.07

0.08

1.6

1.4

—

(3045142) Bone marrow Pathology biopsy report

163

0.91

0.08

1.3

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.13

0.07

3.8

2.6

umol/l

73.7

54.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

468

1.04

0.07

1.5

1.3

miu/ml

291.9

244.8

0.35

221

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1.02

0.07

8.0

10.0

mmol/l

0.7

0.6

—

(4024509)

1.02

0.07

1.3

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

302

3034

0.99

0.07

3.5

3.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.03

0.07

1.1

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

190

1916

0.98

0.07

1.4

1.5

—

(40768795) Lymph node Pathology biopsy report

1.12

0.06

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

510

1.03

0.05

1.9

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

211

0.94

0.05

2.0

—

4.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

197

1.06

0.05

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

431

0.97

0.05

1.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.10

0.04

1.2

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.10

0.04

1.2

1.3

78.2

79.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

100

1.09

0.04

2.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

138

0.93

0.03

2.1

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

187

1840

1.01

0.03

3.8

23.8

21.2

1.00

772

(1001926) Buprenorphine [Presence] in Urine by Screen method

618

0.98

0.03

1.9

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

446

1.02

0.03

1.8

1.7

u/ml

271.3

207.0

0.75

229

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

456

1.02

0.03

1.8

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

137

0.94

0.02

2.1

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

137

0.94

0.02

2.1

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

102

1.07

0.02

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

754

0.99

0.01

1.7

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

196

0.96

0.01

1.8

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

142

1.05

0.01

1.3

nmol/l

0.7

0.6

0.71

134

(3005988) Vibrio sp identified in Specimen by Organism specific culture

136

0.95

0.01

2.1

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

152

1.05

0.01

1.5

1.9

—

(4094501)

251

1.03

0.01

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

139

1372

1.01

0.01

2.6

2.7

ug/l

0.8

0.7

0.23

812

(3000060) B lymphocytes [#/volume] in Blood

165

0.96

0.01

2.6

3.9

e6/l

396.4

383.4

0.03

112

(3025468) Yersinia sp identified in Specimen by Organism specific culture

135

0.96

0.00

2.1

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

135

0.96

0.00

2.1

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

649

1.01

0.00

1.8

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

151

0.99

0.00

1.2

1.3

mmol/l

7.5

7.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

745

1.00

0.00

1.8

1.7

iu/l

23.0

21.0

0.20

555

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

130

0.99

0.00

1.2

1.3

—

(3000330) Specific gravity of Urine by Test strip

499

0.99

0.00

2.9

3.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

207

2057

1.00

0.00

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

171

0.99

0.00

2.4

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

101

0.98

0.00

1.1

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

209

1.00

0.00

3.1

2.4

ug/min

137.4

110.2

0.10

137

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.90

0.00

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.97

0.00

1.1

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.92

0.00

2.3

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.01

0.00

1.2

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

1.4

—

4.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

0.91

0.00

2.3

1.8

ng/l

119.4

126.0

—

(4212803)

0.00

0.0

1.0

—

(3001729) Color of Synovial fluid

0.00

0.0

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

2.8

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.92

0.00

1.0

—

6.8

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

2.9

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

30.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.0

2.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

2.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.97

0.00

1.1

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

592.8

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.89

0.00

1.3

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

829.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

9.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

0.94

0.00

1.0

1.3

nmol/l

121.6

143.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.4

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.0

—

1520.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

7.3

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.1

—

12.3

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.5

—

3.1

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

3.6

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

7.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

3.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

177.9

—

(3015183) Erythrocyte sedimentation rate

0.94

0.00

1.0

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_ASD and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_ASD	1.807 [1.57, 2.09]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.845

During the follow-up period (1.1.1998 — 31.12.2019), 451 out of 5990 females with Q17_ASD died.

Males

Parameter	HR [95% CI]	p-value
Q17_ASD	1.752 [1.5, 2.04]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 363 out of 4494 males with Q17_ASD died.

Mortality risk

Mortality risk for people of age

years, who have Q17_ASD.

N-year risk	Females	Males
1	0.2%	0.337%
5	1.099%	2.003%
10	2.988%	5.23%
15	5.839%	9.857%
20	10.621%	15.809%

Relationships between endpoints

↥

Index endpoint: Q17_ASD – Atrial septal defect

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Atrial septal defect

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints